Abstract Objectives Children with inflammatory bowel disease (IBD) have an increased risk of developing kidney disorders, which may cause significant kidney function impairment (SKI) or lead to chronic kidney disease (CKD). In this study we aimed to provide insights in causes and diagnoses of SKI cases and to provide recommendations for pediatric ...
Stephanie A. Vuijk +16 more
wiley +1 more source
Intranasal sodium citrate solution improves olfaction in post-viral hyposmia [PDF]
Background: Calcium plays an integral role in olfactory signal transduction, including feedback inhibition. Sodium citrate acts as a calcium sequestrant and when applied intranasally, reduces free calcium available for feedback inhibition, which should ...
Cuevas, M +5 more
core
Allopurinol-induced severe cutaneous adverse reactions: A report of three cases with theHLA-B*58:01allele who underwent lymphocyte activation test [PDF]
Eun‐Young Kim +4 more
openalex +1 more source
Biomarkers of iron status in allopurinol-treated renal stone patients [PDF]
Adnan A. Zainal +2 more
openalex +1 more source
A prospective study of HLA*B‐5801 genotyping in preventing allopurinol‐ induced severe cutaneous adverse reactions [PDF]
Tai‐Ming Ko +3 more
openalex +1 more source
What Is Your Diagnosis? Dermal Mass From the Left Forelimb of a Dog
Veterinary Clinical Pathology, EarlyView.
Heather D. McDavid +3 more
wiley +1 more source
P02 Allopurinol counteracts inadequate mercaptopurine metabolism in paediatric acute lymphoblastic leukemia [PDF]
Tiphaine Adam de Beaumais +7 more
openalex +1 more source
Response to Letter Regarding Article, “High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid” [PDF]
Jacob George +4 more
openalex +1 more source
Background Despite the widespread clinical use of allopurinol for managing hepatocellular carcinoma (HCC) and gout, its potential hepatotoxicity and its effect on the risk of HCC remain unclear.
Yu-fu Li +6 more
doaj +1 more source
Rationale & Objective: Clinical trials have shown that serum uric acid reduction does not slow chronic kidney disease (CKD) progression in adults, but it is uncertain whether these findings apply to children.
Derek K. Ng +5 more
doaj +1 more source

